Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Metastasectomy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Lymphatic Metastasis 1 Ependymoma 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Radiotherapy 11 Gemcitabine 7 Doxorubicin 7 Cyclophosphamide 7 pembrolizumab 6 Specimen Handling 6 Magnetic Resonance Spectroscopy 5 Biopsy 5 pazopanib 4 X-Rays 4 Trabectedin 4 Surgical Procedures, Operative 4 Radiation 4 Nivolumab 4 Ifosfamide 4 tazemetostat 3 talimogene laherparepvec 3 fludarabine 3 Temozolomide 3 Standard of Care 3 Phantoms, Imaging 3 Docetaxel 3 Blood Specimen Collection 3 selpercatinib 2 selinexor 2 regorafenib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06815666 2026-03-04

BAL Fluid Biomarkers in Sarcoma

University Health Network, Toronto

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡